Job Posting

Company Overview

28bio is a neurotechnology company engineering human brains at-scale exhibiting memory, learning, and cognitive functions. Its Nexon™ platform integrates tissue engineering, neural interfacing, and AI to reverse today’s neurological health crisis by improving the ability to predict which therapies will work in humans.

The Nexon™ platform also incorporates Organoid Intelligence (OI). The growing field of OI combines human brain organoids with brain-machine interfaces to model memory, learning, and cognition in vitro, offering novel functional cognitive biomarkers with the potential to reshape drug development in neurodegenerative disorders including Alzheimer’s disease.

The Nexon™ platform is now being used to improve the prediction of therapeutic efficacy and toxicity in humans, with several of the world’s largest pharma companies already integrating Nexon™ into their drug development workflows.

Role Summary

The Vice President of Technology will serve as the scientific architect of 28bio—guiding platform evolution, expanding translational relevance, and deepening impact across pharma R&D. This role requires a leader with deep neuroscience expertise, strong cross-disciplinary fluency, and the ability to translate complex science and data into strategic direction and customer messaging.

The Vice President of Technology will serve as the scientific architect of 28bio—guiding platform evolution, expanding translational relevance, and deepening impact across pharma R&D. This role requires a leader with deep neuroscience expertise, strong cross-disciplinary fluency, and the ability to translate complex science and data into strategic direction and customer messaging.

The Vice President of Technology will serve as the scientific architect of 28bio—guiding platform evolution, expanding translational relevance, and deepening impact across pharma R&D. This role requires a leader with deep neuroscience expertise, strong cross-disciplinary fluency, and the ability to translate complex science and data into strategic direction and customer messaging.

‍

Key Responsibilities

Scientific Strategy & Platform Leadership

Define and evolve the scientific roadmap for Nexon platform, with emphasis on neurological relevance and translational unity
Identify and prioritize new use cases, biomarkers, and capabilities that expand platform value across pharma workflows
Translate complex neuroscience into clear, compelling strategy for internal and external stakeholders

Scientific Oversight

Lead development and validation of brain and peripheral nerve organoid models, neural interfaces, and functional assays
Guide integration of AI and computational tools to enhance predictive modeling of therapeutic outcomes
Ensure scientific rigor, reproducibility, and publication-quality data across all programs
Manage scientific teams in New Orleans and Minneapolis

Team & Culture

Build and mentor high-performing team across neurogbiology, tissue engineering, and data science
Foster a culture of curiosity, accountibility, and cross-disciplinary collaboration
Champion diversity in scientific thought and talent

External Engagement

Represent 28bio at scientific conferences and advisory boards
Cultivate strategic partnerships with pharma, academia, and regulatory thought leaders
Support the commercial team with compelling scientific narratives and platform insights

Candidate Profile

Required Experience & Expertise

PhD, or equivalent in neuroscience, neuroengineering, or related life sciences field

10+ years of management experience in the life science tools and platform industry or pharma

Proven track record of advancing neuroscience platforms or models with translational impact

Deep expertise in CNS and PNS disorders

Experience with brain organoids, neural interfacing, or computational neurobiology preferred

Strong understanding of pharma R&D workflows and translational challenges

Leadership Attributes

Strategic thinker with the ability to connect scientific innovation to business outcomes

Exceptional communicator—able to bridge science, strategy, and storytelling

Collaborative, values-driven leader who thrives in fast-paced, high-accountability environments

28bio is not just building a platform—we’re enabling the ability to predict human outcomes.

The Vice President of Technology will play a central role in shaping that transformation, driving scientific excellence, and amplifying our impact across the industry.

We are committed to applying industry best practices and advancing ethical standards in the development of brain organoid technologies, with particular attention to consciousness and sentience.

Vice President of Technology